Mitchell Sinkler & Starr has filed its 13F form on May 07, 2025 for Q1 2025 where it was disclosed a total value porftolio of $353 Million distributed in 152 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Apple Inc. with a value of $21.9M, Microsoft Corp with a value of $21.8M, Abbott Laboratories with a value of $12.3M, Jpmorgan Chase & CO with a value of $11.7M, and Johnson & Johnson with a value of $10.7M.

Examining the 13F form we can see an decrease of $17.5M in the current position value, from $370M to 353M.

Below you can find more details about Mitchell Sinkler & Starr portfolio as well as his latest detailed transactions.

Portfolio value $353 Million
Technology: $76.3 Million
Healthcare: $44.5 Million
ETFs: $44.1 Million
Financial Services: $39.2 Million
Industrials: $36.4 Million
Consumer Defensive: $31 Million
Communication Services: $25.2 Million
Consumer Cyclical: $20.9 Million
Other: $35.3 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 152
  • Current Value $353 Million
  • Prior Value $370 Million
  • Filing
  • Period Q1 2025
  • Filing Date May 07, 2025
  • Form Type 13F-HR
  • Activity in Q1 2025
  • New Purchases 2 stocks
  • Additional Purchases 59 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 65 stocks
Track This Portfolio

Track Mitchell Sinkler & Starr Portfolio

Follow Mitchell Sinkler & Starr and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitchell Sinkler & Starr, based on Form 13F filings with the SEC.

News

Stay updated on Mitchell Sinkler & Starr with notifications on news.